Micronized Estradiol and Progesterone: Effects on Carbohydrate Metabolism in Reproductive-Age Women

Kim L. Thornton, Ralph A. Defronzo, Robert S. Sherwin, Michael Peter Diamond

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: We assessed glucose utilization and insulin sensitivity in normal reproductive-age women after administration of micronized estradiol, micronizedprogesterone, or the combination of micronized estradiol and progesterone. Methods: Hyperglycemic and euglycemic, hyperinsulinemic clamp studies were performed in normal, regularly cycling women both before and after a short course of either micronized estradiol (n = 8), micronized progesterone (n = 8), or micronized estradiol and progesterone (n = 7). All studies were performed after an overnight fast. Glucose and insulin were determined in the control period and then every 2-10 minutes in the hyperglycemic clamp studies and every 5-10 minutes in the euglycemic clamp studies. In the hyperglycemic clamp studies, hyperglycemia was maintained by a variable glucoseinfusion. In the euglycemic clamp studies, a primed 3-3H glucose infusion (25 μCi continuous infusion was begun 120 minutes before initiation of the insulin infusion and variable glucose infusion. Samples for glucose radioactivity were measured during the control period and during the last 40 minutes of each step of the euglycemic clamp after establishment of a steady state. Results: No differences in baseline glucose or insulin levels were detected in any of the study groups as compared with control. Glucose utilization as assessed by the hyperglycemic clamp model was not significantly different from control in the estradiol group, the progesterone group, or the group treated with the combination. In all of the treatment groups, no significant differences were noted under euglycemic, hyperinsulinemic conditions in glucose utilization, hepatic glucoseproduction, or insulin sensitivity. Conclusions: Women of reproductive age do not demonstrate significant differences in basal levels of glucose or insulin when given a short course of micronized estradiol and progesterone, either alone or in combination. Under conditions of the hyperglycemic, hyperinsulinemic clamp, the pancreatic β-cell response to hyperglycemia and glucose utilization is not significantly altered by exogenous administration of hormones. Conditions of the euglycemic, hyperinsulinemic clamp failed to elicit significant differences in glucose utilization and insulin sensitivity in any of the three treatment groups. These findings demonstrate that glucosehomeostasis is not altered by the exogenous administration of natural hormones in reproductive-age women.

Original languageEnglish (US)
Pages (from-to)643-652
Number of pages10
JournalJournal of the Society for Gynecologic Investigation
Volume2
Issue number4
DOIs
StatePublished - Jan 1 1995

Fingerprint

Carbohydrate Metabolism
Progesterone
Estradiol
Glucose
Glucose Clamp Technique
Insulin
Insulin Resistance
Hyperglycemia
Hormones
Radioactivity

Keywords

  • Estradiol
  • euglycemic clamp
  • glucose utilization
  • hyperglycemic clamp
  • insulin sensitivity
  • progesterone

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Micronized Estradiol and Progesterone : Effects on Carbohydrate Metabolism in Reproductive-Age Women. / Thornton, Kim L.; Defronzo, Ralph A.; Sherwin, Robert S.; Diamond, Michael Peter.

In: Journal of the Society for Gynecologic Investigation, Vol. 2, No. 4, 01.01.1995, p. 643-652.

Research output: Contribution to journalArticle

@article{a8ccdcc197d14d00aa084c0d8c2d9764,
title = "Micronized Estradiol and Progesterone: Effects on Carbohydrate Metabolism in Reproductive-Age Women",
abstract = "Objective: We assessed glucose utilization and insulin sensitivity in normal reproductive-age women after administration of micronized estradiol, micronizedprogesterone, or the combination of micronized estradiol and progesterone. Methods: Hyperglycemic and euglycemic, hyperinsulinemic clamp studies were performed in normal, regularly cycling women both before and after a short course of either micronized estradiol (n = 8), micronized progesterone (n = 8), or micronized estradiol and progesterone (n = 7). All studies were performed after an overnight fast. Glucose and insulin were determined in the control period and then every 2-10 minutes in the hyperglycemic clamp studies and every 5-10 minutes in the euglycemic clamp studies. In the hyperglycemic clamp studies, hyperglycemia was maintained by a variable glucoseinfusion. In the euglycemic clamp studies, a primed 3-3H glucose infusion (25 μCi continuous infusion was begun 120 minutes before initiation of the insulin infusion and variable glucose infusion. Samples for glucose radioactivity were measured during the control period and during the last 40 minutes of each step of the euglycemic clamp after establishment of a steady state. Results: No differences in baseline glucose or insulin levels were detected in any of the study groups as compared with control. Glucose utilization as assessed by the hyperglycemic clamp model was not significantly different from control in the estradiol group, the progesterone group, or the group treated with the combination. In all of the treatment groups, no significant differences were noted under euglycemic, hyperinsulinemic conditions in glucose utilization, hepatic glucoseproduction, or insulin sensitivity. Conclusions: Women of reproductive age do not demonstrate significant differences in basal levels of glucose or insulin when given a short course of micronized estradiol and progesterone, either alone or in combination. Under conditions of the hyperglycemic, hyperinsulinemic clamp, the pancreatic β-cell response to hyperglycemia and glucose utilization is not significantly altered by exogenous administration of hormones. Conditions of the euglycemic, hyperinsulinemic clamp failed to elicit significant differences in glucose utilization and insulin sensitivity in any of the three treatment groups. These findings demonstrate that glucosehomeostasis is not altered by the exogenous administration of natural hormones in reproductive-age women.",
keywords = "Estradiol, euglycemic clamp, glucose utilization, hyperglycemic clamp, insulin sensitivity, progesterone",
author = "Thornton, {Kim L.} and Defronzo, {Ralph A.} and Sherwin, {Robert S.} and Diamond, {Michael Peter}",
year = "1995",
month = "1",
day = "1",
doi = "10.1177/107155769500200411",
language = "English (US)",
volume = "2",
pages = "643--652",
journal = "Reproductive Sciences",
issn = "1933-7191",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Micronized Estradiol and Progesterone

T2 - Effects on Carbohydrate Metabolism in Reproductive-Age Women

AU - Thornton, Kim L.

AU - Defronzo, Ralph A.

AU - Sherwin, Robert S.

AU - Diamond, Michael Peter

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Objective: We assessed glucose utilization and insulin sensitivity in normal reproductive-age women after administration of micronized estradiol, micronizedprogesterone, or the combination of micronized estradiol and progesterone. Methods: Hyperglycemic and euglycemic, hyperinsulinemic clamp studies were performed in normal, regularly cycling women both before and after a short course of either micronized estradiol (n = 8), micronized progesterone (n = 8), or micronized estradiol and progesterone (n = 7). All studies were performed after an overnight fast. Glucose and insulin were determined in the control period and then every 2-10 minutes in the hyperglycemic clamp studies and every 5-10 minutes in the euglycemic clamp studies. In the hyperglycemic clamp studies, hyperglycemia was maintained by a variable glucoseinfusion. In the euglycemic clamp studies, a primed 3-3H glucose infusion (25 μCi continuous infusion was begun 120 minutes before initiation of the insulin infusion and variable glucose infusion. Samples for glucose radioactivity were measured during the control period and during the last 40 minutes of each step of the euglycemic clamp after establishment of a steady state. Results: No differences in baseline glucose or insulin levels were detected in any of the study groups as compared with control. Glucose utilization as assessed by the hyperglycemic clamp model was not significantly different from control in the estradiol group, the progesterone group, or the group treated with the combination. In all of the treatment groups, no significant differences were noted under euglycemic, hyperinsulinemic conditions in glucose utilization, hepatic glucoseproduction, or insulin sensitivity. Conclusions: Women of reproductive age do not demonstrate significant differences in basal levels of glucose or insulin when given a short course of micronized estradiol and progesterone, either alone or in combination. Under conditions of the hyperglycemic, hyperinsulinemic clamp, the pancreatic β-cell response to hyperglycemia and glucose utilization is not significantly altered by exogenous administration of hormones. Conditions of the euglycemic, hyperinsulinemic clamp failed to elicit significant differences in glucose utilization and insulin sensitivity in any of the three treatment groups. These findings demonstrate that glucosehomeostasis is not altered by the exogenous administration of natural hormones in reproductive-age women.

AB - Objective: We assessed glucose utilization and insulin sensitivity in normal reproductive-age women after administration of micronized estradiol, micronizedprogesterone, or the combination of micronized estradiol and progesterone. Methods: Hyperglycemic and euglycemic, hyperinsulinemic clamp studies were performed in normal, regularly cycling women both before and after a short course of either micronized estradiol (n = 8), micronized progesterone (n = 8), or micronized estradiol and progesterone (n = 7). All studies were performed after an overnight fast. Glucose and insulin were determined in the control period and then every 2-10 minutes in the hyperglycemic clamp studies and every 5-10 minutes in the euglycemic clamp studies. In the hyperglycemic clamp studies, hyperglycemia was maintained by a variable glucoseinfusion. In the euglycemic clamp studies, a primed 3-3H glucose infusion (25 μCi continuous infusion was begun 120 minutes before initiation of the insulin infusion and variable glucose infusion. Samples for glucose radioactivity were measured during the control period and during the last 40 minutes of each step of the euglycemic clamp after establishment of a steady state. Results: No differences in baseline glucose or insulin levels were detected in any of the study groups as compared with control. Glucose utilization as assessed by the hyperglycemic clamp model was not significantly different from control in the estradiol group, the progesterone group, or the group treated with the combination. In all of the treatment groups, no significant differences were noted under euglycemic, hyperinsulinemic conditions in glucose utilization, hepatic glucoseproduction, or insulin sensitivity. Conclusions: Women of reproductive age do not demonstrate significant differences in basal levels of glucose or insulin when given a short course of micronized estradiol and progesterone, either alone or in combination. Under conditions of the hyperglycemic, hyperinsulinemic clamp, the pancreatic β-cell response to hyperglycemia and glucose utilization is not significantly altered by exogenous administration of hormones. Conditions of the euglycemic, hyperinsulinemic clamp failed to elicit significant differences in glucose utilization and insulin sensitivity in any of the three treatment groups. These findings demonstrate that glucosehomeostasis is not altered by the exogenous administration of natural hormones in reproductive-age women.

KW - Estradiol

KW - euglycemic clamp

KW - glucose utilization

KW - hyperglycemic clamp

KW - insulin sensitivity

KW - progesterone

UR - http://www.scopus.com/inward/record.url?scp=0029049945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029049945&partnerID=8YFLogxK

U2 - 10.1177/107155769500200411

DO - 10.1177/107155769500200411

M3 - Article

C2 - 9420871

AN - SCOPUS:0029049945

VL - 2

SP - 643

EP - 652

JO - Reproductive Sciences

JF - Reproductive Sciences

SN - 1933-7191

IS - 4

ER -